News
Bayer announced an FDA review extension for Elinzanetant, its experimental menopausal hot flash therapy. Approval remains on track. REad more here.
Whether you have prediabetes, type 1 diabetes, or type 2 diabetes, it’s important to ensure you are testing your blood sugar levels enough to monitor your condition and guide effective treatment.
A target A1C of 7% is a common goal for adults with diabetes, helping reduce long-term complications and improve blood sugar control.
Bayer said its Nubeqa treatment was approved by the EU for advanced prostate cancer. The German pharmaceutical and agricultural conglomerate said the European Commission granted approval of Nubeqa ...
Bayer Leverkusen were stunned during their first pre-season friendly under Erik ten Hag.
Nearly 1 in 3 American adolescents have prediabetes, a CDC report finds. An official notes "it’s not too late to change course." ...
The U.S. Supreme Court asked President Donald Trump's administration on Monday for its views on Bayer's bid to sharply limit lawsuits claiming that the company's Roundup weedkiller causes cancer ...
The Supreme Court is seeking input from the nation's top lawyer before deciding whether to take up a petition sought by Bayer on the reach of federal pesticide law.
Bayer-owned BlueRock Therapeutics is laying off 50 employees and shuttering its research labs in Cambridge, Massachusetts, in order to focus its resources on its priority cell therapies.
Lilly's once-weekly insulin efsitora alfa demonstrated A1C reduction and a safety profile consistent with daily insulin in multiple Phase 3 trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results